Universitätsklinikum Schleswig-Holstein (UKSH)

Hospital


Location: Lübeck / Kiel, Germany (DE) DE

ISNI: 0000000406462097

ROR: https://ror.org/01tvm6f46

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1 (2021) Neirich L, Yahiaoui-Doktor M, Lammert J, Basrai M, Seethaler B, Berling-Ernst A, Ramser J, et al. Journal article Consent to research participation: understanding and motivation among German pupils (2021) Reetz J, Richter G, Borzikowsky C, Glinicke C, Darabaneanu S, Buyx A Journal article Analysis of tripartite motif (TRIM) family gene expression in prostate cancer bone metastases (2021) Offermann A, Kang D, Watermann C, Weingart A, Hupe MC, Saraji A, Stegmann-Frehse J, et al. Journal article Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative (2021) Kayser S, Schlenk RF, Lebon D, Carre M, Goetze KS, Stoelzel F, Berceanu A, et al. Journal article Technical validation of real-world monitoring of gait: a multicentric observational study (2021) Mazza C, Alcock L, Aminian K, Becker C, Bertuletti S, Bonci T, Brown P, et al. Journal article Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program (2021) Müller V, Banys-Paluchowski M, Friedl TW, Fasching P, Schneeweiss A, Hartkopf A, Wallwiener D, et al. Journal article Correction to: Innovative radiation oncology Together—Precise, Personalized, Human: Vision 2030 for radiotherapy & radiation oncology in Germany (Strahlentherapie und Onkologie, (2021), 197, 12, (1043-1048), 10.1007/s00066-021-01843-9) (2021) Krug D, Hecht M, Ebert N, Maurer M, Fleischmann DF, Fokas E, Straube C, et al. Journal article, Erratum Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML (2021) Jaramillo S, Krisam J, Le Cornet L, Kratzmann M, Baumann L, Sauer T, Crysandt M, et al. Journal article Influence of Turkish origin on hematology reference intervals in the German population (2021) Mayr FX, Bertram A, Cario H, Frühwald MC, Groß HJ, Groening A, Grützner S, et al. Journal article DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status (2021) Jurmeister P, Weber K, Villegas S, Karn T, Untch M, Thieme A, Mueller V, et al. Journal article